logo Digitalia
Recherche avancée
2019 Nelson's Pediatric Antimicrobial Therapy (25th ed.)

2019 Nelson's Pediatric Antimicrobial Therapy (25th ed.)

  • Auteur: Bradley, John S. (ed.)
  • Éditeur: American Academy of Pediatrics
  • ISBN: 9781610022101
  • eISBN Pdf: 9781610022262
  • Lieu de publication:  Illinois , United States
  • Année: 2019
  • Pages: 320

Viewers online:

  • ReadSpeaker

    Download options

  • Adobe DRM Adobe DRM
    Non disponible
  • Available
  • Mode: Loan
  • Loan duration: 20 days
  • Permissions: Read
  • Format: PDF
Inscrivez-vous pour des fonctions supplémentaires


This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of infectious diseases in children.

For each disease, the authors provide a commentary to help health care professionals select the best of all antimicrobial choices. Drug descriptions cover pediatric appropriate antimicrobials agents and complete information about dosing regimens. In response to growing concerns about overuse of antibiotics, the program includes guidelines on when not to prescribe antimicrobials.

Now in color to help you find the best options quickly!

New in the 25th edition:

  • Includes recommendations for new intravenous broad-spectrum beta-lactam/beta-lactamase inhibitor combinations.
  • Provides options for treatment of increasing resistance in Escherichia coli for urinary tract infections.
  • Includes updates for management of diarrhea.
  • Simplifies navigation with color-coded tabs and tables that make it easier to find the best treatment options for susceptibility of bacterial, fungal, viral, and parasitic pathogens.
  • Clarifies specific, new, and evolving recommendations about antifungal therapeutic drug levels for several invasive fungal infections, particularly in immunocompromised children.
  • Reorganizes antiviral table for easier reading: common viral pathogens are in one table and HIV, hepatitis B, and hepatitis C are in a second table.
  • Provides guidance for neonates during the ongoing cefotaxime shortage, including alternatives to achieve similar antibacterial activity in similar tissue sites, with a similar safety profile.
  • Includes updates, such as new information on drug therapy and steroid therapy for neurocysticercosis, incorporating the new IDSA and American Society of Tropical Medicine and Hygiene guidelines.
  • Incorporates new IDSA coccidioidomycosis guidelines in updated recommendations.